KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.345
Today's Change
0.00 (0.00%)
Day's Change
0.345 - 0.35
Trading Volume
1,340,000
Market Cap
1,677 Million
NOSH
4,860 Million
Latest Quarter
31-Aug-2024 [#1]
Announcement Date
21-Oct-2024
Next Quarter
30-Nov-2024
Est. Ann. Date
18-Mar-2025
Est. Ann. Due Date
29-Jan-2025
QoQ | YoY
2.66% | 0.00%
Revenue | NP to SH
168,985.000 | 54,192.000
RPS | P/RPS
3.48 Cent | 9.92
EPS | P/E | EY
1.12 Cent | 30.94 | 3.23%
DPS | DY | Payout %
1.10 Cent | 3.19% | 98.43%
NAPS | P/NAPS
0.04 | 8.63
QoQ | YoY
36.12% | null%
NP Margin | ROE
32.84% | 27.88%
F.Y. | Ann. Date
31-Aug-2024 | 21-Oct-2024
Latest Audited Result
31-May-2024
Announcement Date
30-Sep-2024
Next Audited Result
31-May-2025
Est. Ann. Date
30-Sep-2025
Est. Ann. Due Date
27-Nov-2025
Revenue | NP to SH
167,586.000 | 52,933.000
RPS | P/RPS
3.45 Cent | 10.01
EPS | P/E | EY
1.15 Cent | 31.68 | 3.16%
DPS | DY | Payout %
0.70 Cent | 2.03% | 64.27%
NAPS | P/NAPS
0.04 | 8.63
YoY
null%
NP Margin | ROE
32.26% | 27.23%
F.Y. | Ann. Date
31-May-2024 | 17-Jul-2024
Revenue | NP to SH
171,980.000 | 57,524.000
RPS | P/RPS
3.54 Cent | 9.75
EPS | P/E | EY
1.20 Cent | 29.15 | 3.43%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
8.67% | null%
NP Margin | ROE
34.76% | 29.59%
F.Y. | Ann. Date
31-Aug-2024 | 21-Oct-2024
Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Keputusan q1nya amat cemerlang. Sekarang kita tunggu bisnesnya di Filipina, Indo dan China menjana lebih pendapatan pd suku seterusnya
3 weeks ago
Even Aminvest's price target is way above the current market fair value, this also implies that the stock is currently undervalued.
3 weeks ago
Aminvest gives ALPHA a target price of 42 cents by the way
https://www.dagangnews.com/article/terkini/aminvestment-kekal-saranan-beli-dengan-fv-42-sen-ke-atas-alpha-ivf-43689
2 weeks ago
Alpha IVF’s profit margins for FY2024 to FY2026 are x2 the average of its regional peers, definitely can hit 0.42
2 weeks ago
With the good fundamentals, sure it wouldn't be a problem for Alpha IVF to hit 0.42
2 weeks ago
Alpha's market share is larger than Metro and has more solid financial performance. So, personally I prefer Alpha
2 weeks ago
Just buy both :)) IPO is a good chance to in cheap, so far Metro just operating in locals while Alpha already started to expand overseas
2 weeks ago
Alpha IVF Group Bhd is accelerating its growth across Southeast Asia with strategic expansions into key markets such as Indonesia, China and the Philippines, looking to position itself as a regional leader in fertility care
2 weeks ago
https://www.nst.com.my/business/corporate/2024/10/1127062/alpha-ivf-accelerate-growth-plans-indonesia-china-and-philippines
The company is preparing to open two more IVF centres in Malaysia by FY2026, bringing the total number of centres in the country to 5
2 weeks ago
https://www.businesstoday.com.my/2024/10/29/alpha-expands-within-asean-and-to-china-commits-to-60-net-profit-distribution/
Consistent dividend payment coming soon. Stay tuned
2 weeks ago
2 more new IVF centre, oversea expansion + distributing at least 60% of the annual net profit to shareholders, good moves by ALPHA
2 weeks ago
Opening new outlets required time to grow... Long run is good. Short term profit should be reducing due to higher costs I.e rental, staff costs and etc
2 weeks ago
Don’t worry, revenue from Indonesia, China and the Philippines will offset the increased administrative costs
1 week ago
In the AGM, Alpha had mentioned that Alhaya, the 51.0% owned specialists centre of Alpha IVF, is expected to cater for the largely untapped Muslim market, both domestically and internationally.
1 week ago
This company is turning into blue chip soon, if they keep on expanding and execute their dividend payment plan
1 week ago
5. ORDINARY RESOLUTION 5
Description Authority To Directors Pursuant To Sections 75 And 76 Of The Companies Act 2016.
what is this
1 week ago
@stevenckheng. It's a provision that allows the directors of a company to issue new shares without seeking prior approval from shareholders for each issuance
1 week ago
The benefit of this resolution is to enable directors to effectively manage fundraising efforts or issue new shares within a predetermined range approved by shareholders to support business operations, strategic partnerships and expansion plans
1 week ago
Quick review from ALPHA AGM last friday
https://klse.i3investor.com/web/blog/detail/OddesyOne/2024-11-01-story-h472908510-Top_5_Things_I_Learned_from_Alpha_IVF_s_2024_AGM
1 week ago
Alhaya, pusat pakar Alpha IVF, dijangka memenuhi sebahagian besar pasaran Muslim di dalam dan di luar negara. Selain itu, Alhaya terletak di Hospital Pakar KPJ Damansara 2, dan ini akan memanfaatkan Alpha IVF dgn aliran pelanggan berpotensi yg byk
1 week ago
ALPHA will be the SEA regional leader in fertility care with more expansion into Indonesia and the Philippines, stay for the long term growth & dividend
1 week ago
People nowadays are conscious of the fertility care, this is one of the drivers of their long term growth
1 week ago
Heard that ALPHA is inventing a machine called "SHOOGLE" that mimics the womb and will apply for a patent for the machine
1 week ago
Alhaya, Alpha IVF’s 51%-owned specialist center, is set to serve the largely untapped Muslim market both locally and internationally. Located within KPJ Damansara Specialist Hospital 2, this partnership enables Alpha IVF to tap into a strong client base by collaborating closely with KPJ.
1 week ago
Alpha IVF Group Berhad stands out for its use of cutting-edge technology in reproductive health. Their advanced techniques, like preimplantation genetic testing and precision lab facilities, really put them at the forefront of fertility treatment in the region.
1 week ago
The success rates achieved by Alpha IVF are among the best in the industry, which speaks volumes about their expertise and dedication to patient outcomes.
1 week ago
Alpha is the top Fertility Hospital of the Year, of course success rate are high with averaging up to 87.5%, and the successful delivery of more than 7,000 IVF babies
1 week ago
The company has won many world firsts in the field of fertility. Consider it's a strong moat
1 week ago
The growing prevalence of infertility among couples, ongoing advancements in IVF technology, and changing societal attitudes toward family have all driven the rising demand for IVF services, giving ALPHA a highly promising outlook !
5 days ago
ALPHA provides a comprehensive range of fertility services under one roof, which really simplifies things for patients. From IVF and ICSI to cryopreservation and genetic testing, their wide array of services makes them a strong threat for the competitors in the market
3 days ago
Fertility specialist Alpha IVF continues to deliver remarkably high pregnancy success rates, superior margins and canny focus on target markets amid rising affluence and low IVF penetration rates in the region position ahead of peers.
3 days ago
Let's follow the boss buying 😁
https://klse.i3investor.com/web/insider/detail/D_182262_1566210842
2 days ago
Nice, Alpha IVF scales up in Singapore with 3 new specialists
https://www.nst.com.my/business/corporate/2024/11/1133223/alpha-ivf-scales-singapore-3-new-specialists
1 day ago
bagus, Dato Dr Lee kumpul lagi
https://klse.i3investor.com/web/insider/detail/D_182300_1081034373
8 hours ago
Alpha IVF Singapore now has one of the largest IVF teams in the country, capable of handling up to 1,000 IVF cycles annually which aligns with the Singaporean government's efforts to address the nation's declining birth rate by providing high-quality fertility services.
2 hours ago
CASHewnut
So far prospect is pretty bright due to continued growth in foreign patients to Malaysian operations, new full-fledged centres in Malaysia, the Philippines and Indonesia and new representative offices in China and satellite clinics in Indonesia.
3 weeks ago